| Name | Title | Contact Details |
|---|
InteliFUSE is a New Orleans, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MEDX Ventures Group, founded in 2010, is an investment and management company with offices in Israel, USA and Europe. The company believes in active management (as opposed to passive investment), and is focusing on medical ventures and technologies in Israel while utilizing the Company`s unique X Model to include its core Development, Regulatory, Commercial and Finance team that manages a portfolio of ventures. MEDX Ventures Group capitalizes on its global presence while utilizing Israel`s unique research, development and operations capabilities in the field; As such the company focuses on smart investment, reduced risk, short time to market and efficient return on investment. MEDX Ventures Group is led by highly experienced medical device management and investment team from different aspects of the business to ensure the Company`s X Model is fully implemented and executed in each of its activities and ventures. In addition, the company continuously seeks alliances with global industry leaders, beginning in project development stage, to ensure medical innovations become the life changing reality for patients and providers, while becoming a profitable business to all stakeholders and generating attractive return for investors.
Since its inception in 1970, Microcopy has been at the forefront in the design and development of diamond and carbide burs for the dental industry. Our NeoDiamond product line—America`s #1 selling diamond—is among the most respected in the dental marketplace. Our team of engineers, marketers and production experts design, package and perform complete product inspections following our ISO-certified quality management system. Because we are a full-service solution for our customers, we are able to provide unparalleled support complete with a 100% performance guarantee. Our mission at Microcopy is to provide a strong sense of satisfaction to each customer by offering truly innovative, effective, high-value products. This combined with a courteous and responsive customer service team is what keeps our loyal customers coming back and inspires them to spread the word about our products to their peers.
With a growing demand for behavioral health services and a shortage of providers, access to care is challenging. Telepsychiatry is a solution to bridge this gap in care. innovaTel has nationwide network of psychiatrists, nurse practitioners and licensed clinical social workers that connect to organizations virtually through telemedicine.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.